These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1723835)

  • 21. The effects of recombinant human insulin-like growth factor-I (IGF-I) administration on the levels of IGF-I, IGF-II and IGF-binding proteins in adolescents with insulin-dependent diabetes mellitus.
    Cheetham TD; Taylor A; Holly JM; Clayton K; Cwyfan-Hughes S; Dunger DB
    J Endocrinol; 1994 Aug; 142(2):367-74. PubMed ID: 7523562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
    Bang P; Brismar K; Rosenfeld RG; Hall K
    J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
    Muñoz MT; Barrios V; Pozo J; Argente J
    Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system.
    Thrailkill K; Quattrin T; Baker L; Litton J; Dwigun K; Rearson M; Poppenheimer M; Kotlovker D; Giltinan D; Gesundheit N; Martha P
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1181-7. PubMed ID: 9100593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in growth hormone concentrations during puberty in adolescents with insulin dependent diabetes.
    Batch JA; Werther GA
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):411-6. PubMed ID: 1424174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
    Carroll PV; Umpleby M; Alexander EL; Egel VA; Callison KV; Sönksen PH; Russell-Jones DL
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.
    Argente J; Caballo N; Barrios V; Muñoz MT; Pozo J; Chowen JA; Morandé G; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2084-92. PubMed ID: 9215276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucagon stimulates insulin-like growth factor binding protein-1 secretion in healthy subjects, patients with pituitary insufficiency, and patients with insulin-dependent diabetes mellitus.
    Hilding A; Brismar K; Thorén M; Hall K
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1142-7. PubMed ID: 7521339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.
    Edge JA; Matthews DR; Dunger DB
    Clin Endocrinol (Oxf); 1990 Dec; 33(6):729-37. PubMed ID: 2096008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa.
    Golden NH; Kreitzer P; Jacobson MS; Chasalow FI; Schebendach J; Freedman SM; Shenker IR
    J Pediatr; 1994 Oct; 125(4):655-60. PubMed ID: 7523649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.
    Hartman ML; Clayton PE; Johnson ML; Celniker A; Perlman AJ; Alberti KG; Thorner MO
    J Clin Invest; 1993 Jun; 91(6):2453-62. PubMed ID: 8514857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
    Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus.
    Bereket A; Lang CH; Wilson TA
    Horm Metab Res; 1999; 31(2-3):172-81. PubMed ID: 10226799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent effects of recombinant human insulin-like growth factor (IGF)-I/IGF binding protein-3 complex on overnight growth hormone secretion and insulin sensitivity in type 1 diabetes.
    Saukkonen T; Amin R; Williams RM; Fox C; Yuen KC; White MA; Umpleby AM; Acerini CL; Dunger DB
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4634-41. PubMed ID: 15356074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus.
    Christ ER; Carroll PV; Albany E; Umpleby AM; Lumb PJ; Wierzbicki AS; Simpson HL; Sönksen PH; Russell-Ones DL
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):777-87. PubMed ID: 11895220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics.
    Taylor AM; Dunger DB; Preece MA; Holly JM; Smith CP; Wass JA; Patel S; Tate VE
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):229-39. PubMed ID: 1693321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.